Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Lynn Taylor

Research Professor

University of Rhode Island - College of Pharmacy

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Pharmacotherapy

100%

Virology

90%

Antiviral Therapy

100%

Substance Abuse Treatment

60%

Hepatitis C

60%

Hiv

40%

Drug Utilization

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles16

Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study

Article Link

Year:

2024

Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study

Article Link

Year:

2024

Test characteristics for combining non‐invasive liver fibrosis staging modalities in individuals with Hepatitis C virus

Article Link

Year:

2024

A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and Experiences

Article Link

Year:

2023

The experience of re-infection among people who inject drugs successfully treated for hepatitis C

Article Link

Year:

2023

Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study

Article Link

Year:

2023

Evaluation of intervention components to maximize yoga practice among people with chronic pain taking opioid agonist therapy: A factorial experiment using the multiphase optimization strategy framework.

Article Link

Year:

2023

Shame and stigma in association with the HCV cascade to cure among people who inject drugs.

Article Link

Year:

2023

Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial.

Article Link

Year:

2022

The effect of antiretroviral therapy with high central nervous system penetration on HIV-related cognitive impairment: a systematic review and meta-analysis.

Article Link

Year:

2022

Treatment for hepatitis C virus with direct acting antiviral agents: Perspectives and treatment experiences of people who inject drugs.

Article Link

Year:

2022

A Randomized Trial Comparing Brief Advice and Motivational Interviewing for Persons with HIV-HCV Co-infection Who Drink Alcohol.

Article Link

Year:

2020

Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program.

Article Link

Year:

2020

Diversity of the hepatitis C virus NS5B gene during HIV co-infection.

Article Link

Year:

2020

Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics.

Article Link

Year:

2020

Successful Kidney Transplantation in a Recipient Coinfected with Hepatitis C Genotype 2 and HIV from a Donor Infected with Hepatitis C Genotype 1 in the Direct-Acting Antiviral Era.

Article Link

Year:

2020

Collaborators8

Rachel Epstein

Boston University School of Medicine

UNITED STATES

Alain Litwin

Professor

Clemson University

UNITED STATES

Irene Pericot-Valverde

Clemson University

UNITED STATES

Michael D. Stein

Boston University School of Public Health

UNITED STATES

Moonseong Heo

Professor

Clemson University

UNITED STATES

Virginia Lijewski

University of Colorado Anschutz Medical Campus

UNITED STATES

judith feinberg

Vice Chair of Medicine for Research, Professor

West Virginia University Rockefeller Neuroscience Institute

UNITED STATES

Kimberly Page

Professor and Division Chief, Epidemiology, Biostatistics & Preventive Medicine

University of New Mexico Health Sciences Center

UNITED STATES

How do I reach out?

Meet Kite AI